文献速递心律失常心力衰竭与心肌病血脂与心血管预防

年轻个体猝死的基因组尸检研究

Genomic Autopsy of Sudden Deaths in Young Individuals.
PubMed 文献 · JAMA Cardiol · 2021-01-01

该研究对103例年轻猝死者(平均年龄23.7岁)及其家属进行全基因组测序和临床评估,在12.6%的死者中检出心律失常或心肌病基因的致病/可能致病变异。年轻死者携带更多致病/可能致病变异,且死者中特定意义未明变异和罕见心脏变异均多于对照,提示寡基因累加风险机制。

要点

  • 全基因组测序在12.6%的年轻猝死者中检出心律失常或心肌病基因的致病/可能致病变异。
  • 年轻死者携带致病/可能致病变异及特定意义未明变异的负担更高。
  • 死者罕见心脏变异数多于对照(2.3 vs 1.8/人),提示寡基因累加风险。

核心结论

  • 全基因组测序可有效识别年轻猝死者中涉及心律失常和心肌病基因的致病/可能致病变异。
  • 基因组分析和家族表型关联提示该队列猝死可能存在潜在累加的寡基因风险机制。

研究设计与样本

  • 对2015年5月至2019年3月从美国24个州法医网络前瞻性招募的猝死年轻死者进行病理和全基因组序列分析。
  • 共分析103例死者(平均年龄23.7岁,范围1-44岁)、其存活家庭成员及140名性别和遗传祖先匹配的对照。

主要发现

  • 在103例死者中,36例有尸检后诊断,23例为意义不确定的发现,44例为不明原因猝死。
  • 13例死者(12.6%)检出心律失常或心肌病基因的致病/可能致病变异。

关键数值与推荐

  • 31个父母-死者三联体和14个父母-死者二联体的基因检测发现8个传递的致病/可能致病变异和1个新发致病/可能致病变异。
  • 8名传递致病/可能致病变异的父母中有6名存在不完全外显。

临床怎么用

  • 对年轻猝死者应整合尸检、临床数据和全基因组测序进行基因组尸检评估。
  • 检出致病/可能致病变异后应对存活家庭成员进行遗传评估和表型筛查。
  • 评估时需注意不完全外显和寡基因累加风险的可能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Postmortem genetic testing of young individuals with sudden death has previously identified pathogenic gene variants. However, prior studies primarily considered highly penetrant monogenic variants, often without detailed decedent and family clinical information. OBJECTIVE: To assess genotype and phenotype risk in a diverse cohort of young decedents with sudden death and their families. DESIGN, SETTING, AND PARTICIPANTS: Pathological and whole-genome sequence analysis was conducted in a cohort referred from a national network of medical examiners. Cases were accrued prospectively from May 2015 to March 2019 across 24 US states. Analysis began September 2016 and ended November 2020. EXPOSURES: Evaluation of autopsy and clinical data integrated with whole-genome sequence data and family member evaluation. RESULTS: A total of 103 decedents (mean [SD] age at death, 23.7 [11.9] years; age range, 1-44 years), their surviving family members, and 140 sex- and genetic ancestry-matched controls were analyzed. Among 103 decedents, autopsy and clinical data review categorized 36 decedents with postmortem diagnoses, 23 decedents with findings of uncertain significance, and 44 with sudden unexplained death. Pathogenic/likely pathogenic (P/LP) genetic variants in arrhythmia or cardiomyopathy genes were identified in 13 decedents (12.6%). A multivariable analysis including decedent phenotype, ancestry, and sex demonstrated that younger decedents had a higher burden of P/LP variants and select variants of uncertain significance (effect size, -1.64; P = .001). These select, curated variants of uncertain significance in cardiac genes were more common in decedents than controls (83 of 103 decedents [86%] vs 100 of 140 controls [71%]; P = .005), and decedents harbored more rare cardiac variants than controls (2.3 variants per individual vs 1.8 in controls; P = .006). Genetic testing of 31 parent-decedent trios and 14 parent-decedent dyads revealed 8 transmitted P/LP variants and 1 de novo P/LP variant. Incomplete penetrance was present in 6 of 8 parents who transmitted a P/LP variant. CONCLUSIONS AND RELEVANCE: Whole-genome sequencing effectively identified P/LP variants in cases of sudden death in young individuals, implicating both arrhythmia and cardiomyopathy genes. Genomic analyses and familial phenotype association suggest potentially additive, oligogenic risk mechanisms for sudden death in this cohort.

来源:JAMA Cardiol,查看原文。版权归原作者所有。

引用

  1. Webster G, Puckelwartz MJ, Pesce LL, et al. Genomic Autopsy of Sudden Deaths in Young Individuals. JAMA Cardiol. 2021. PMID: 34379075. doi:10.1001/jamacardio.2021.2789

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。